Which medication is used to maintain the ductus arteriosus in the management of Hypoplastic Left Heart Syndrome?

Which medication is used to maintain the ductus arteriosus in the management of Hypoplastic Left Heart Syndrome?

• A. Prostaglandins
• B. Beta blockers
• C. Calcium channel blockers
• D. Antibiotics

Answer: (A)

In hypoplastic left heart syndrome, the systemic circulation relies on a patent ductus arteriosus for blood to reach the body from the right side of the heart. Giving prostaglandin E1 keeps the ductus arteriosus open, preventing its natural closure after birth and ensuring ongoing blood flow to the systemic circulation while surgical Norwood palliation or other stabilization steps are planned. Prostaglandins relax the smooth muscle of the ductus, maintaining patency at a low, continuous dose. The other options don’t achieve this goal: beta blockers lower heart rate and contractility and won’t keep the ductus open; calcium channel blockers aren’t used to maintain ductal patency and can even promote closure in some scenarios; antibiotics don’t affect ductus tone or patency. Prostaglandin therapy is the standard approach to support circulation in ductus-dependent lesions like HLHS.

In hypoplastic left heart syndrome, the systemic circulation relies on a patent ductus arteriosus for blood to reach the body from the right side of the heart. Giving prostaglandin E1 keeps the ductus arteriosus open, preventing its natural closure after birth and ensuring ongoing blood flow to the systemic circulation while surgical Norwood palliation or other stabilization steps are planned. Prostaglandins relax the smooth muscle of the ductus, maintaining patency at a low, continuous dose.

The other options don’t achieve this goal: beta blockers lower heart rate and contractility and won’t keep the ductus open; calcium channel blockers aren’t used to maintain ductal patency and can even promote closure in some scenarios; antibiotics don’t affect ductus tone or patency. Prostaglandin therapy is the standard approach to support circulation in ductus-dependent lesions like HLHS.